hydroxyproline has been researched along with flutamide in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lynch, JH; O'Brien, WM | 1 |
| Gold, E; Goulding, A | 1 |
| Arakawa, T; Hashimoto, T; Itoh, M; Joh, T; Kuno, A; Nakamura, S; Nakazawa, T; Nomura, T; Ohara, H; Sano, H; Sogawa, M; Takahashi, S; Yamada, T | 1 |
3 other study(ies) available for hydroxyproline and flutamide
| Article | Year |
|---|---|
Hydroxyproline as a marker for following patients with metastatic prostate cancer.
Topics: Bone Neoplasms; Buserelin; Creatinine; Flutamide; Follow-Up Studies; Gonadotropin-Releasing Hormone; Humans; Hydroxyproline; Leuprolide; Male; Prostatic Neoplasms | 1988 |
Flutamide-mediated androgen blockade evokes osteopenia in the female rat.
Topics: Androgens; Animals; Body Weight; Bone Density; Bone Diseases, Metabolic; Buserelin; Female; Flutamide; Hydroxyproline; Organ Size; Rats; Rats, Wistar; Uterus | 1993 |
Estradiol alleviates acinar cell apoptosis and chronic pancreatitis in male Wistar Bonn/Kobori rats.
Topics: Androgen Antagonists; Animals; Apoptosis; Body Weight; Cell Movement; Chronic Disease; Estradiol; Flutamide; Hormones; Hydroxyproline; Male; Organ Size; Pancreas; Pancreatitis; Rats; Rats, Inbred Strains; Rats, Wistar; Receptors, Androgen; Spleen; T-Lymphocytes | 2003 |